respiratory
Infectious diseases

Fully oral regimens for MDR-TB should help improve compliance: WHO


A rapid communication issued by the WHO highlights the immediate steps to be taken to ensure that people with multidrug resistant tuberculosis or rifampicin resistant tuberculosis receive treatment in accordance with the latest evidence on effectiveness and safety. “While understanding that it would not be immediately possible to achieve the new standards of care in every individual multidrug resistant ...

Already a member?

Enter your email to keep reading.


OR